Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
27 July, 2017 12:10 IST
Lupin receives USFDA nod for generic Seroquel XR tablets
Source: IRIS | 19 May, 2017, 08.20AM
Comments  |  Post Comment

Pharma Major Lupin announced today that it has received final approval for its Quetiapine Fumarate Extended-Release Tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg from the United States Food and Drug Administration (FDA) to market a generic version of AstraZeneca Pharmaceuticals LP's Seroquel XR Tablets 50 mg, 150 mg, 200 mg, 300 mg and 400 mg.

Lupin's Quetiapine Fumarate Extended-Release Tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg are the AB rated generic equivalent of AstraZeneca Pharmaceuticals LP's Seroquel XR Tablets 50 mg, 150 mg, 200 mg, 300 mg and 400 mg.

It is indicated for the treatment of schizophrenia; acute manic or mixed episodes in bipolar I disorder alone or as an adjunct to lithium or divalproex; acute depressive episodes in bipolar disorder; maintenance treatment of bipolar I disorder, as an adjunct to lithium or divalproex and as an adjunctive therapy to antidepressants for the treatment of major depressive disorder.

Seroquel XR Extended-Release Tablets had US sales of USD 1.27 billion (IMS MAT March 2017).

Shares of the company gained Rs 7.85, or 0.61%, to trade at  Rs 1,304.90.  The total volume of shares traded  was  67,273 at the BSE (4.01 p.m., Thursday).



Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
SSPDL inks JDA for development of premium residential apartments in Chennai - 27-Jul-2017 11:19
Tata Motors expands range of commercial vehicles in Philippines - 27-Jul-2017 10:22
VA Tech Wabag bags STP order worth Rs 3.86 bn - 27-Jul-2017 10:13
HCL Technologies quarterly net up 8% - 27-Jul-2017 09:09
Maruti Suzuki launches first NEXA Service workshop at Gurugram - 27-Jul-2017 08:50
Yes Bank Q1 earnings jump 31.9% to Rs 9.65 bn - 26-Jul-2017 16:11
MBL Infra selects Welspun Ent as sponsorer for two projects - 26-Jul-2017 13:43
Hero Motocorp quarterly net rises 4% - 26-Jul-2017 10:57
TD Power Systems bags order for supply of traction motor components - 26-Jul-2017 10:24
Cipla in partnership with MMV launches quality-assured RAS - 26-Jul-2017 10:19
Suzlon wins 50.40 MW overseas wind power project - 26-Jul-2017 09:50
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer